| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.9 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0097 | 0.9 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |